Table 2 Multivariate analysis for patients with AML in primary relapse

 UD vs MSD

0.76 (0.64–0.89)

<0.01

 Age^a

0.99 (0.99–1.00)

0.02

 Time from dx to Tx >9 months

0.62 (0.53–0.72)

<0.01

 Female donor to male recipient

0.91 (0.74–1.11)

0.35

 sAML

0.99 (0.79–1.23)

0.92

 previous auto-HSCT

1.22 (0.86–1.73)

0.26

 Positive recipient CMV serology

0.96 (0.80–1.15)

0.68

 Positive donor CMV serology

1.03 (0.86–1.22)

0.77

 RIC

1.21 (1.02–1.42)

0.03

 UD vs MSD

1.04 (0.80–1.35)

0.79

 Age^a

1.02 (1.01–1.03)

<0.01

 Time from dx to Tx >9 months

0.82 (0.64–1.06)

0.12

 Female donor to male recipient

0.86 (0.62–1.21)

0.40

 sAML

1.39 (1.03–1.87)

0.03

 previous auto-HSCT

1.49 (0.91–2.43)

0.11

 Positive recipient CMV serology

0.98 (0.74–1.30)

0.89

 Positive donor CMV serology

0.98 (0.74–1.28)

0.86

 RIC

0.96 (0.74–1.24)

0.74

 UD vs MSD

0.83 (0.72–0.96)

0.01

 Age^a

1.00 (0.99–1.00)

0.82

 Time from dx to Tx >9 months

0.67 (0.59–0.77)

<0.01

 Female donor to male recipient

0.90 (0.75–1.07)

0.22

 sAML

1.11 (0.93–1.32)

0.26

 previous auto-HSCT

1.29 (0.97–1.71)

0.08

 Positive recipient CMV serology

0.97 (0.84–1.13)

0.72

 Positive donor CMV serology

1.01 (0.87–1.17)

0.87

 RIC

1.13 (0.98–1.30)

0.09

 UD vs MSD

0.89 (0.77–1.03)

0.12

 Age^a

1.00 (1.00–1.01)

0.36

 Time from dx to Tx >9 months

0.71 (0.61–0.81)

<0.01

 Female donor to male recipient

0.86 (0.72–1.03)

0.10

 sAML

1.09 (0.91–1.31)

0.34

 previous auto-HSCT

1.25 (0.93–1.68)

0.15

 Positive recipient CMV serology

0.96 (0.82–1.12)

0.61

 Positive donor CMV serology

0.99 (0.85–1.16)

0.92

 RIC

1.01 (0.88–1.17)

0.88